We are live on
!
Find out more
iBio
IBIO
IBIO
16 hedge funds and large institutions have $3.37M invested in iBio in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
61% more capital invested
Capital invested by funds: $2.1M → $3.37M (+$1.27M)
0% more funds holding
Funds holding: 16 → 16 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
–
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACP
Arcus Capital Partners
Atlanta,
Georgia
|
+$1.95M |
| 2 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
+$97.2K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$6.27K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$28.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$22K |
| 3 |
Millennium Management
New York
|
-$7K |
| 4 |
Bank of New York Mellon
New York
|
-$6.27K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$2K |
